We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Consumer Discretionary 15.2%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENLK
151
DELISTED
EnLink Midstream Partners, LP
ENLK
$4.22M 0.1%
134,350
+1,000
+0.7% +$30.6K
NPK icon
152
National Presto Industries
NPK
$870M
$4.22M 0.1%
57,950
– –
IBKC
153
DELISTED
IBERIABANK Corp
IBKC
$4.21M 0.1%
60,820
-75
-0.1% -$4.91K
ROSE
154
DELISTED
ROSETTA RESOURCES INC
ROSE
$4.21M 0.1%
76,710
+20
+0% +$972
ZWS icon
155
Zurn Elkay Water Solutions
ZWS
$7.96B
$4.12M 0.1%
304,020
+114
+0% +$1.51K
PBH icon
156
Prestige Consumer Healthcare
PBH
$2.36B
$4.1M 0.1%
121,125
+200
+0.2% +$6.41K
GMED icon
157
Globus Medical
GMED
$10.5B
$4.1M 0.1%
171,550
-200
-0.1% -$4.82K
HP icon
158
Helmerich & Payne
HP
$3.41B
$4.07M 0.1%
35,030
-25,030
-42% -$2.74M
ACHC icon
159
Acadia Healthcare
ACHC
$3.17B
$4.02M 0.1%
88,365
+35,330
+67% +$1.55M
DORM icon
160
Dorman Products
DORM
$4.24B
$3.98M 0.09%
80,760
-40
-0% -$2.18K
CBU icon
161
Community Bank
CBU
$3.62B
$3.96M 0.09%
109,545
-630
-0.6% -$23.3K
ABT icon
162
Abbott
ABT
$175B
$3.96M 0.09%
51,345
+50,045
+3,850% +$1.97M
EPAY
163
DELISTED
Bottomline Technologies Inc
EPAY
$3.93M 0.09%
131,340
+5,000
+4% +$154K
EVTC icon
164
Evertec
EVTC
$1.87B
$3.92M 0.09%
161,600
-20
-0% -$477
CHD icon
165
Church & Dwight Co
CHD
$23.2B
$3.85M 0.09%
110,100
– –
XLNX
166
DELISTED
Xilinx Inc
XLNX
$3.79M 0.09%
80,075
– –
GNTX icon
167
Gentex
GNTX
$5.19B
$3.79M 0.09%
+260,250
New +$3.8M
APTV icon
168
Aptiv
APTV
$12.2B
$3.78M 0.09%
55,050
– –
CATM
169
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$3.78M 0.09%
110,945
+9,865
+10% +$330K
CAVM
170
DELISTED
Cavium, Inc.
CAVM
$3.76M 0.09%
75,710
-20,435
-21% -$940K
FFBC icon
171
First Financial Bancorp
FFBC
$3.75B
$3.76M 0.09%
218,354
+6,750
+3% +$113K
THO icon
172
Thor Industries
THO
$3.97B
$3.73M 0.09%
65,660
+70
+0.1% +$4.2K
WWAV
173
DELISTED
The WhiteWave Foods Company
WWAV
$3.73M 0.09%
115,110
-35,040
-23% -$1.05M
TNGO
174
DELISTED
Tangoe, Inc.
TNGO
$3.73M 0.09%
247,380
+9,925
+4% +$154K
HBAN icon
175
Huntington Bancshares
HBAN
$37B
$3.72M 0.09%
390,385
+60,100
+18% +$565K
5 6
7
8 9

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.